fda compounding semaglutide crackdown november 2025 Compounded GLP-1s Become Illegal, Price Cuts Roll Out FDA restricts non-approved compounded GLP-1

Individuals who have tried dieting and exercise alone without seeing the results they want may also benefit from the enhanced metabolic support

If your current provider is unfamiliar with or opposed to this approach, functional medicine practitioners and integrative rheumatologists are more likely to have experience with GLP-1 microdosing for autoimmune applications

Oral alternatives that are FDA-approved Foundayo (orforglipron) Eli Lillys Foundayo was approved by the FDA on April 1, 2026 for weight management in adults with obesity or overweight with at least one weight-related condition

Others may experience cramps or flatulence

Popko, P